Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010081264) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DIABETIC NEPHROPATHY AND PREPARATION METHOD THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/081264 International Application No.: PCT/CN2009/000352
Publication Date: 22.07.2010 International Filing Date: 01.04.2009
IPC:
A61K 31/352 (2006.01) ,A61K 31/7048 (2006.01) ,A61P 3/10 (2006.01) ,A61P 13/12 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7048
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13
Drugs for disorders of the urinary system
12
of the kidneys
Applicants:
广州康臣药物研究有限公司 GUANGZHOU CONSUN MEDICINE R & D CO., LTD. [CN/CN]; 中国广东省广州市 经济技术开发区东区东鹏大道71号 No.71, Dongpeng Road Eastern District, Economy Technology Development Park Guangzhou, Guangdong 510530, CN (AllExceptUS)
朱荃 ZHU, Quan [CN/CN]; CN (UsOnly)
石兴华 SHI, Xinghua [CN/CN]; CN (UsOnly)
汤丹 TANG, Dan [CN/CN]; CN (UsOnly)
郑兆广 ZHENG, Zhaoguang [CN/CN]; CN (UsOnly)
何宝 HE, Bao [CN/CN]; CN (UsOnly)
段婷婷 DUAN, Tingting [CN/CN]; CN (UsOnly)
顾斐 GU, Fei [CN/CN]; CN (UsOnly)
程慧荃 CHENG, Huiquan [CN/CN]; CN (UsOnly)
黄晓玲 HUANG, Xiaoling [CN/CN]; CN (UsOnly)
黄艳霞 HUANG, Yanxia [CN/CN]; CN (UsOnly)
王汝上 WANG, Rushang [CN/CN]; CN (UsOnly)
Inventors:
朱荃 ZHU, Quan; CN
石兴华 SHI, Xinghua; CN
汤丹 TANG, Dan; CN
郑兆广 ZHENG, Zhaoguang; CN
何宝 HE, Bao; CN
段婷婷 DUAN, Tingting; CN
顾斐 GU, Fei; CN
程慧荃 CHENG, Huiquan; CN
黄晓玲 HUANG, Xiaoling; CN
黄艳霞 HUANG, Yanxia; CN
王汝上 WANG, Rushang; CN
Agent:
广州华进联合专利商标代理有限公司 ADVANCE CHINA I. P. LAW OFFICE; 中国广东省广州市 先烈中路69号东山广场918-920室曾旻辉/赵磊 ZENG, Minhui/ZHAO, Lei Suite 918-920, 9/F., Dong Shan Plaza No.69 Xianlie Central Road Guangzhou, Guangdong 510095, CN
Priority Data:
200910036717.016.01.2009CN
Title (EN) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DIABETIC NEPHROPATHY AND PREPARATION METHOD THEREOF
(FR) COMPOSITION PHARMACEUTIQUE DE PRÉVENTION ET TRAITEMENT D'UNE NÉPHROPATHIE DIABÉTIQUE ET SON PROCÉDÉ DE PRÉPARATION
(ZH) 一种防治糖尿病肾病的药物组合物及其制备方法
Abstract:
(EN) A pharmaceutical composition for preventing and treating diabetic nephropathy and a preparation method thereof, and the use of calycosin and/or calycosin-7-o-β-D-glucopyranoside in the preparation of a medicament for preventing and treating diabetic nephropathy are provided. The pharmaceutical composition consists of active component which is one or both of calycosin and calycosin-7-o-β-D- glucopyranoside, and a pharmaceutically acceptable carrier. The content of the active component is 0.1-99.5wt%.
(FR) L'invention porte sur une composition pharmaceutique destiné à prévenir et traiter une néphropathie diabétique et sur son procédé de préparation, et sur l'utilisation de la calycosine et/ou du calycosine-7-o-β-D-glucopyranoside dans la préparation d'un médicament destiné à prévenir et traiter une néphropathie diabétique. La composition pharmaceutique consiste en un composant actif qui est l'un ou les deux parmi la calycosine et le calycosine-7-o-β-D-glucopyranoside, et un support pharmaceutiquement acceptable. La teneur en composant actif est comprise entre 0,1 et 99,5 % en poids.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)
Also published as:
EP2380570JP2011527284US20110053872KR1020100103539IN4547/DELNP/2010